1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Phage Therapy Market Size 2016-2026 2.1.2 Phage Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026 2.2 Phage Therapy Segment by Type 2.2.1 DsDNA Bacteriophage 2.2.2 DsDNA Bacteriophage 2.2.3 SsRNA Bacteriophage 2.2.4 Others 2.3 Phage Therapy Market Size by Type 2.3.1 Global Phage Therapy Market Size CAGR by Type 2.3.2 Global Phage Therapy Market Size Market Share by Type (2016-2021) 2.4 Phage Therapy Segment by Application 2.4.1 Animal Health 2.4.2 Aquaculture 2.4.3 Agriculture 2.4.4 Food Industry 2.4.5 Human Health 2.4.6 Others 2.5 Phage Therapy Market Size by Application 2.5.1 Global Phage Therapy Market Size CAGR by Application 2.5.2 Global Phage Therapy Market Size Market Share by Application (2016-2021) 3 Phage Therapy Market Size by Players 3.1 Phage Therapy Market Size Market Share by Players 3.1.1 Global Phage Therapy Revenue by Players (2019-2021E) 3.1.2 Global Phage Therapy Revenue Market Share by Players (2019-2021E) 3.2 Global Phage Therapy Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Phage Therapy by Regions 4.1 Phage Therapy Market Size by Regions (2016-2021) 4.2 Americas Phage Therapy Market Size Growth (2016-2021) 4.3 APAC Phage Therapy Market Size Growth (2016-2021) 4.4 Europe Phage Therapy Market Size Growth (2016-2021) 4.5 Middle East & Africa Phage Therapy Market Size Growth (2016-2021) 5 Americas 5.1 Americas Phage Therapy Market Size by Country (2016-2021) 5.2 Americas Phage Therapy Market Size by Type (2016-2021) 5.3 Americas Phage Therapy Market Size by Application (2016-2021) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Phage Therapy Market Size by Region (2016-2021) 6.2 APAC Phage Therapy Market Size by Type (2016-2021) 6.3 APAC Phage Therapy Market Size by Application (2016-2021) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Phage Therapy by Country (2016-2021) 7.2 Europe Phage Therapy Market Size by Type (2016-2021) 7.3 Europe Phage Therapy Market Size by Application (2016-2021) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Phage Therapy by Region (2016-2021) 8.2 Middle East & Africa Phage Therapy Market Size by Type (2016-2021) 8.3 Middle East & Africa Phage Therapy Market Size by Application (2016-2021) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Global Phage Therapy Market Forecast 10.1 Global Phage Therapy Forecast by Regions (2021-2026) 10.1.1 Global Phage Therapy Forecast by Regions (2021-2026) 10.1.2 Americas Phage Therapy Forecast 10.1.3 APAC Phage Therapy Forecast 10.1.4 Europe Phage Therapy Forecast 10.1.5 Middle East & Africa Phage Therapy Forecast 10.2 Americas Phage Therapy Forecast by Countries (2021-2026) 10.2.1 United States Phage Therapy Market Forecast 10.2.2 Canada Phage Therapy Market Forecast 10.2.3 Mexico Phage Therapy Market Forecast 10.2.4 Brazil Phage Therapy Market Forecast 10.3 APAC Phage Therapy Forecast by Region (2021-2026) 10.3.1 China Phage Therapy Market Forecast 10.3.2 Japan Phage Therapy Market Forecast 10.3.3 Korea Phage Therapy Market Forecast 10.3.4 Southeast Asia Phage Therapy Market Forecast 10.3.5 India Phage Therapy Market Forecast 10.3.6 Australia Phage Therapy Market Forecast 10.4 Europe Phage Therapy Forecast by Country (2021-2026) 10.4.1 Germany Phage Therapy Market Forecast 10.4.2 France Phage Therapy Market Forecast 10.4.3 UK Phage Therapy Market Forecast 10.4.4 Italy Phage Therapy Market Forecast 10.4.5 Russia Phage Therapy Market Forecast 10.5 Middle East & Africa Phage Therapy Forecast by Region (2021-2026) 10.5.1 Egypt Phage Therapy Market Forecast 10.5.2 South Africa Phage Therapy Market Forecast 10.5.3 Israel Phage Therapy Market Forecast 10.5.4 Turkey Phage Therapy Market Forecast 10.5.5 GCC Countries Phage Therapy Market Forecast 10.6 Global Phage Therapy Forecast by Type (2021-2026) 10.7 Global Phage Therapy Forecast by Application (2021-2026) 11 Key Players Analysis 11.1 NPO Microgen 11.1.1 NPO Microgen Company Information 11.1.2 NPO Microgen Phage Therapy Product Offered 11.1.3 NPO Microgen Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.1.4 NPO Microgen Main Business Overview 11.1.5 NPO Microgen Latest Developments 11.2 Proteon Pharmaceuticals 11.2.1 Proteon Pharmaceuticals Company Information 11.2.2 Proteon Pharmaceuticals Phage Therapy Product Offered 11.2.3 Proteon Pharmaceuticals Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.2.4 Proteon Pharmaceuticals Main Business Overview 11.2.5 Proteon Pharmaceuticals Latest Developments 11.3 Phagelux 11.3.1 Phagelux Company Information 11.3.2 Phagelux Phage Therapy Product Offered 11.3.3 Phagelux Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.3.4 Phagelux Main Business Overview 11.3.5 Phagelux Latest Developments 11.4 Intralytix 11.4.1 Intralytix Company Information 11.4.2 Intralytix Phage Therapy Product Offered 11.4.3 Intralytix Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.4.4 Intralytix Main Business Overview 11.4.5 Intralytix Latest Developments 11.5 Micreos 11.5.1 Micreos Company Information 11.5.2 Micreos Phage Therapy Product Offered 11.5.3 Micreos Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.5.4 Micreos Main Business Overview 11.5.5 Micreos Latest Developments 11.6 Eliava BioPreparations 11.6.1 Eliava BioPreparations Company Information 11.6.2 Eliava BioPreparations Phage Therapy Product Offered 11.6.3 Eliava BioPreparations Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.6.4 Eliava BioPreparations Main Business Overview 11.6.5 Eliava BioPreparations Latest Developments 11.7 Locus Biosciences,Inc 11.7.1 Locus Biosciences,Inc Company Information 11.7.2 Locus Biosciences,Inc Phage Therapy Product Offered 11.7.3 Locus Biosciences,Inc Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.7.4 Locus Biosciences,Inc Main Business Overview 11.7.5 Locus Biosciences,Inc Latest Developments 11.8 Pharmex Group,LLC 11.8.1 Pharmex Group,LLC Company Information 11.8.2 Pharmex Group,LLC Phage Therapy Product Offered 11.8.3 Pharmex Group,LLC Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.8.4 Pharmex Group,LLC Main Business Overview 11.8.5 Pharmex Group,LLC Latest Developments 11.9 Pherecydes Pharma 11.9.1 Pherecydes Pharma Company Information 11.9.2 Pherecydes Pharma Phage Therapy Product Offered 11.9.3 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.9.4 Pherecydes Pharma Main Business Overview 11.9.5 Pherecydes Pharma Latest Developments 11.10 APS Biocontrol Ltd. (APS) 11.10.1 APS Biocontrol Ltd. (APS) Company Information 11.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Offered 11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.10.4 APS Biocontrol Ltd. (APS) Main Business Overview 11.10.5 APS Biocontrol Ltd. (APS) Latest Developments 11. Qingdao Phagepharm Bio-tech 11.11.1 Qingdao Phagepharm Bio-tech Company Information 11.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Offered 11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.11.4 Qingdao Phagepharm Bio-tech Main Business Overview 11.11.5 Qingdao Phagepharm Bio-tech Latest Developments 11.12 Fixed-Phage Limited 11.12.1 Fixed-Phage Limited Company Information 11.12.2 Fixed-Phage Limited Phage Therapy Product Offered 11.12.3 Fixed-Phage Limited Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.12.4 Fixed-Phage Limited Main Business Overview 11.12.5 Fixed-Phage Limited Latest Developments 11.13 Zeptometrix 11.13.1 Zeptometrix Company Information 11.13.2 Zeptometrix Phage Therapy Product Offered 11.13.3 Zeptometrix Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.13.4 Zeptometrix Main Business Overview 11.13.5 Zeptometrix Latest Developments 11.14 Phage International, Inc. 11.14.1 Phage International, Inc. Company Information 11.14.2 Phage International, Inc. Phage Therapy Product Offered 11.14.3 Phage International, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.14.4 Phage International, Inc. Main Business Overview 11.14.5 Phage International, Inc. Latest Developments 11.15 MicroMir 11.15.1 MicroMir Company Information 11.15.2 MicroMir Phage Therapy Product Offered 11.15.3 MicroMir Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.15.4 MicroMir Main Business Overview 11.15.5 MicroMir Latest Developments 11.16 iNtODEWORLD, Inc. 11.16.1 iNtODEWORLD, Inc. Company Information 11.16.2 iNtODEWORLD, Inc. Phage Therapy Product Offered 11.16.3 iNtODEWORLD, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.16.4 iNtODEWORLD, Inc. Main Business Overview 11.16.5 iNtODEWORLD, Inc. Latest Developments 11.17 NEXTBIOTICS 11.17.1 NEXTBIOTICS Company Information 11.17.2 NEXTBIOTICS Phage Therapy Product Offered 11.17.3 NEXTBIOTICS Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.17.4 NEXTBIOTICS Main Business Overview 11.17.5 NEXTBIOTICS Latest Developments 11.18 Armata Pharmaceuticals, Inc. 11.18.1 Armata Pharmaceuticals, Inc. Company Information 11.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Offered 11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.18.4 Armata Pharmaceuticals, Inc. Main Business Overview 11.18.5 Armata Pharmaceuticals, Inc. Latest Developments 11.19 Innophage 11.19.1 Innophage Company Information 11.19.2 Innophage Phage Therapy Product Offered 11.19.3 Innophage Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.19.4 Innophage Main Business Overview 11.19.5 Innophage Latest Developments 11.20 Adaptive Phage Therapeutics 11.20.1 Adaptive Phage Therapeutics Company Information 11.20.2 Adaptive Phage Therapeutics Phage Therapy Product Offered 11.20.3 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.20.4 Adaptive Phage Therapeutics Main Business Overview 11.20.5 Adaptive Phage Therapeutics Latest Developments 11.21 TechnoPhage 11.21.1 TechnoPhage Company Information 11.21.2 TechnoPhage Phage Therapy Product Offered 11.21.3 TechnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.21.4 TechnoPhage Main Business Overview 11.21.5 TechnoPhage Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. Phage Therapy Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of DsDNA Bacteriophage Table 3. Major Players of SsDNA Bacteriophage Table 4. Major Players of SsRNA Bacteriophage Table 5. Major Players of Others Table 6. Phage Therapy Market Size CAGR by Type (2020-2026) & ($ Millions) Table 7. Global Phage Therapy Market Size by Type (2016-2021) & ($ Millions) Table 8. Global Phage Therapy Market Size Market Share by Type (2016-2021) Table 9. Phage Therapy Market Size CAGR by Application (2016-2021) & ($ Millions) Table 10. Global Phage Therapy Market Size by Application (2016-2021) & ($ Millions) Table 11. Global Phage Therapy Market Size Market Share by Application (2016-2021) Table 12. Global Phage Therapy Revenue by Players (2019-2021E) & ($ Millions) Table 13. Global Phage Therapy Revenue Market Share by Players (2019-2021E) Table 14. Phage Therapy Key Players Head office and Products Offered Table 15. Phage Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Phage Therapy Market Size by Regions 2016-2021 & ($ Millions) Table 19. Global Phage Therapy Market Size Market Share by Regions 2016-2021 Table 20. Americas Phage Therapy Market Size by Country (2016-2021) & ($ Millions) Table 21. Americas Phage Therapy Market Size Market Share by Country (2016-2021) Table 22. Americas Phage Therapy Market Size by Type (2016-2021) & ($ Millions) Table 23. Americas Phage Therapy Market Size Market Share by Type (2016-2021) Table 24. Americas Phage Therapy Market Size by Application (2016-2021) & ($ Millions) Table 25. Americas Phage Therapy Market Size Market Share by Application (2016-2021) Table 26. APAC Phage Therapy Market Size by Region (2016-2021) & ($ Millions) Table 27. APAC Phage Therapy Market Size Market Share by Region (2016-2021) Table 28. APAC Phage Therapy Market Size by Type (2016-2021) & ($ Millions) Table 29. APAC Phage Therapy Market Size Market Share by Type (2016-2021) Table 30. APAC Phage Therapy Market Size by Application (2016-2021) & ($ Millions) Table 31. APAC Phage Therapy Market Size Market Share by Application (2016-2021) Table 32. Europe Phage Therapy Market Size by Country (2016-2021) & ($ Millions) Table 33. Europe Phage Therapy Market Size Market Share by Country (2016-2021) Table 34. Europe Phage Therapy Market Size by Type (2016-2021) & ($ Millions) Table 35. Europe Phage Therapy Market Size Market Share by Type (2016-2021) Table 36. Europe Phage Therapy Market Size by Application (2016-2021) & ($ Millions) Table 37. Europe Phage Therapy Market Size Market Share by Application (2016-2021) Table 38. Middle East & Africa Phage Therapy Market Size by Region (2016-2021) & ($ Millions) Table 39. Middle East & Africa Phage Therapy Market Size Market Share by Region (2016-2021) Table 40. Middle East & Africa Phage Therapy Market Size by Type (2016-2021) & ($ Millions) Table 41. Middle East & Africa Phage Therapy Market Size Market Share by Type (2016-2021) Table 42. Middle East & Africa Phage Therapy Market Size by Application (2016-2021) & ($ Millions) Table 43. Middle East & Africa Phage Therapy Market Size Market Share by Application (2016-2021) Table 44. Key and Potential Regions of Phage Therapy Table 45. Key Application and Potential Industries of Phage Therapy Table 46. Key Challenges of Phage Therapy Table 47. Key Trends of Phage Therapy Table 48. Global Phage Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 49. Global Phage Therapy Market Size Market Share Forecast by Regions (2021-2026) Table 50. Global Phage Therapy Market Size Forecast by Type (2021-2026) & ($ Millions) Table 51. Global Phage Therapy Market Size Market Share Forecast by Type (2021-2026) Table 52. Global Phage Therapy Market Size Forecast by Application (2021-2026) & ($ Millions) Table 53. Global Phage Therapy Market Size Market Share Forecast by Application (2021-2026) Table 54. NPO Microgen Details, Company Type, Phage Therapy Area Served and Its Competitors Table 55. NPO Microgen Phage Therapy Product Offered Table 56. NPO Microgen Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 57. NPO Microgen Main Business Table 58. NPO Microgen Latest Developments Table 59. Proteon Pharmaceuticals Details, Company Type, Phage Therapy Area Served and Its Competitors Table 60. Proteon Pharmaceuticals Phage Therapy Product Offered Table 61. Proteon Pharmaceuticals Main Business Table 62. Proteon Pharmaceuticals Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 63. Proteon Pharmaceuticals Latest Developments Table 64. Phagelux Details, Company Type, Phage Therapy Area Served and Its Competitors Table 65. Phagelux Phage Therapy Product Offered Table 66. Phagelux Main Business Table 67. Phagelux Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 68. Phagelux Latest Developments Table 69. Intralytix Details, Company Type, Phage Therapy Area Served and Its Competitors Table 70. Intralytix Phage Therapy Product Offered Table 71. Intralytix Main Business Table 72. Intralytix Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 73. Intralytix Latest Developments Table 74. Micreos Details, Company Type, Phage Therapy Area Served and Its Competitors Table 75. Micreos Phage Therapy Product Offered Table 76. Micreos Main Business Table 77. Micreos Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 78. Micreos Latest Developments Table 79. Eliava BioPreparations Details, Company Type, Phage Therapy Area Served and Its Competitors Table 80. Eliava BioPreparations Phage Therapy Product Offered Table 81. Eliava BioPreparations Main Business Table 82. Eliava BioPreparations Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 83. Eliava BioPreparations Latest Developments Table 84. Locus Biosciences,Inc Details, Company Type, Phage Therapy Area Served and Its Competitors Table 85. Locus Biosciences,Inc Phage Therapy Product Offered Table 86. Locus Biosciences,Inc Main Business Table 87. Locus Biosciences,Inc Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 88. Locus Biosciences,Inc Latest Developments Table 89. Pharmex Group,LLC Details, Company Type, Phage Therapy Area Served and Its Competitors Table 90. Pharmex Group,LLC Phage Therapy Product Offered Table 91. Pharmex Group,LLC Main Business Table 92. Pharmex Group,LLC Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 93. Pharmex Group,LLC Latest Developments Table 94. Pherecydes Pharma Details, Company Type, Phage Therapy Area Served and Its Competitors Table 95. Pherecydes Pharma Phage Therapy Product Offered Table 96. Pherecydes Pharma Main Business Table 97. Pherecydes Pharma Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 98. Pherecydes Pharma Latest Developments Table 99. APS Biocontrol Ltd. (APS) Details, Company Type, Phage Therapy Area Served and Its Competitors Table 100. APS Biocontrol Ltd. (APS) Phage Therapy Product Offered Table 101. APS Biocontrol Ltd. (APS) Main Business Table 102. APS Biocontrol Ltd. (APS) Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 103. APS Biocontrol Ltd. (APS) Latest Developments Table 104. Qingdao Phagepharm Bio-tech Details, Company Type, Phage Therapy Area Served and Its Competitors Table 105. Qingdao Phagepharm Bio-tech Phage Therapy Product Offered Table 106. Qingdao Phagepharm Bio-tech Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 107. Qingdao Phagepharm Bio-tech Main Business Table 108. Qingdao Phagepharm Bio-tech Latest Developments Table 109. Fixed-Phage Limited Details, Company Type, Phage Therapy Area Served and Its Competitors Table 110. Fixed-Phage Limited Phage Therapy Product Offered Table 111. Fixed-Phage Limited Main Business Table 112. Fixed-Phage Limited Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 113. Fixed-Phage Limited Latest Developments Table 114. Zeptometrix Details, Company Type, Phage Therapy Area Served and Its Competitors Table 115. Zeptometrix Phage Therapy Product Offered Table 116. Zeptometrix Main Business Table 117. Zeptometrix Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 118. Zeptometrix Latest Developments Table 119. Phage International, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors Table 120. Phage International, Inc. Phage Therapy Product Offered Table 121. Phage International, Inc. Main Business Table 122. Phage International, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 123. Phage International, Inc. Latest Developments Table 124. MicroMir Details, Company Type, Phage Therapy Area Served and Its Competitors Table 125. MicroMir Phage Therapy Product Offered Table 126. MicroMir Main Business Table 127. MicroMir Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 128. MicroMir Latest Developments Table 129. iNtODEWORLD, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors Table 130. iNtODEWORLD, Inc. Phage Therapy Product Offered Table 131. iNtODEWORLD, Inc. Main Business Table 132. iNtODEWORLD, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 133. iNtODEWORLD, Inc. Latest Developments Table 134. NEXTBIOTICS Details, Company Type, Phage Therapy Area Served and Its Competitors Table 135. NEXTBIOTICS Phage Therapy Product Offered Table 136. NEXTBIOTICS Main Business Table 137. NEXTBIOTICS Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 138. NEXTBIOTICS Latest Developments Table 139. Armata Pharmaceuticals, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors Table 140. Armata Pharmaceuticals, Inc. Phage Therapy Product Offered Table 141. Armata Pharmaceuticals, Inc. Main Business Table 142. Armata Pharmaceuticals, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 143. Armata Pharmaceuticals, Inc. Latest Developments Table 144. Innophage Details, Company Type, Phage Therapy Area Served and Its Competitors Table 145. Innophage Phage Therapy Product Offered Table 146. Innophage Main Business Table 147. Innophage Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 148. Innophage Latest Developments Table 149. Adaptive Phage Therapeutics Details, Company Type, Phage Therapy Area Served and Its Competitors Table 150. Adaptive Phage Therapeutics Phage Therapy Product Offered Table 151. Adaptive Phage Therapeutics Main Business Table 152. Adaptive Phage Therapeutics Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 153. Adaptive Phage Therapeutics Latest Developments Table 154. TechnoPhage Details, Company Type, Phage Therapy Area Served and Its Competitors Table 155. TechnoPhage Phage Therapy Product Offered Table 156. TechnoPhage Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 157. TechnoPhage Main Business Table 158. TechnoPhage Latest Developments List of Figures Figure 1. Phage Therapy Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Phage Therapy Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Phage Therapy Market Size Market Share by Type in 2020 Figure 7. Phage Therapy in Animal Health Figure 8. Global Phage Therapy Market: Animal Health (2016-2021) & ($ Millions) Figure 9. Phage Therapy in Aquaculture Figure 10. Global Phage Therapy Market: Aquaculture (2016-2021) & ($ Millions) Figure 11. Phage Therapy in Agriculture Figure 12. Global Phage Therapy Market: Agriculture (2016-2021) & ($ Millions) Figure 13. Phage Therapy in Food Industry Figure 14. Global Phage Therapy Market: Food Industry (2016-2021) & ($ Millions) Figure 15. Phage Therapy in Human Health Figure 16. Global Phage Therapy Market: Human Health (2016-2021) & ($ Millions) Figure 17. Phage Therapy in Others Figure 18. Global Phage Therapy Market: Others (2016-2021) & ($ Millions) Figure 19. Global Phage Therapy Market Size Market Share by Application in 2020 Figure 20. Global Phage Therapy Revenue Market Share by Player in 2020 Figure 21. Global Phage Therapy Market Size Market Share by Regions (2016-2021) Figure 22. Americas Phage Therapy Market Size 2016-2021 ($ Millions) Figure 23. APAC Phage Therapy Market Size 2016-2021 ($ Millions) Figure 24. Europe Phage Therapy Market Size 2016-2021 ($ Millions) Figure 25. Middle East & Africa Phage Therapy Market Size 2016-2021 ($ Millions) Figure 26. Americas Phage Therapy Market Size Market Share by Country in 2020 Figure 27. Americas Phage Therapy Market Size Market Share by Type in 2020 Figure 28. Americas Phage Therapy Market Size Market Share by Application in 2020 Figure 29. United States Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 30. Canada Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 31. Mexico Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 32. APAC Phage Therapy Market Size Market Share by Regions in 2020 Figure 33. APAC Phage Therapy Market Size Market Share by Type in 2020 Figure 34. APAC Phage Therapy Market Size Market Share by Application in 2020 Figure 35. China Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 36. Japan Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 37. Korea Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 38. Southeast Asia Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 39. India Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 40. Australia Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 41. Europe Phage Therapy Market Size Market Share by Country in 2020 Figure 42. Europe Phage Therapy Market Size Market Share by Type in 2020 Figure 43. Europe Phage Therapy Market Size Market Share by Application in 2020 Figure 44. Germany Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 45. France Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 46. UK Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 47. Italy Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 48. Russia Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 49. Middle East & Africa Phage Therapy Market Size Market Share by Region in 2020 Figure 50. Middle East & Africa Phage Therapy Market Size Market Share by Type in 2020 Figure 51. Middle East & Africa Phage Therapy Market Size Market Share by Application in 2020 Figure 52. Egypt Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 53. South Africa Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 54. Israel Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 55. Turkey Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 56. GCC Country Phage Therapy Market Size Growth 2016-2021 ($ Millions) Figure 57. Americas Phage Therapy Market Size 2021-2026 ($ Millions) Figure 58. APAC Phage Therapy Market Size 2021-2026 ($ Millions) Figure 59. Europe Phage Therapy Market Size 2021-2026 ($ Millions) Figure 60. Middle East & Africa Phage Therapy Market Size 2021-2026 ($ Millions) Figure 61. United States Phage Therapy Market Size 2021-2026 ($ Millions) Figure 62. Canada Phage Therapy Market Size 2021-2026 ($ Millions) Figure 63. Mexico Phage Therapy Market Size 2021-2026 ($ Millions) Figure 64. Brazil Phage Therapy Market Size 2021-2026 ($ Millions) Figure 65. China Phage Therapy Market Size 2021-2026 ($ Millions) Figure 66. Japan Phage Therapy Market Size 2021-2026 ($ Millions) Figure 67. Korea Phage Therapy Market Size 2021-2026 ($ Millions) Figure 68. Southeast Asia Phage Therapy Market Size 2021-2026 ($ Millions) Figure 69. India Phage Therapy Market Size 2021-2026 ($ Millions) Figure 70. Australia Phage Therapy Market Size 2021-2026 ($ Millions) Figure 71. Germany Phage Therapy Market Size 2021-2026 ($ Millions) Figure 72. France Phage Therapy Market Size 2021-2026 ($ Millions) Figure 73. UK Phage Therapy Market Size 2021-2026 ($ Millions) Figure 74. Italy Phage Therapy Market Size 2021-2026 ($ Millions) Figure 75. Russia Phage Therapy Market Size 2021-2026 ($ Millions) Figure 76. Spain Phage Therapy Market Size 2021-2026 ($ Millions) Figure 77. Egypt Phage Therapy Market Size 2021-2026 ($ Millions) Figure 78. South Africa Phage Therapy Market Size 2021-2026 ($ Millions) Figure 79. Israel Phage Therapy Market Size 2021-2026 ($ Millions) Figure 80. Turkey Phage Therapy Market Size 2021-2026 ($ Millions) Figure 81. GCC Country Phage Therapy Market Size 2021-2026 ($ Millions)